• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
OTLK

OTLK

Outlook Therapeutics, Inc.

NASDAQHealthcareBiotechnologyUS

USD0.81

-0.00 (-0.47%)

Rating:C

Company Profile

CEO

Robert Charles Jahr

IPO Date

2016-06-14

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$0.80

Prev. Close

$0.81

Day Low

$0.73

Day High

$0.82

52W Low

$0.16

52W High

$3.39

Market Cap

$0.03B

Volume

10.48M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

29.5%

Avg Negative

13.8%

Avg Neutral

56.5%

News Feed

Hot Penny Stocks to Buy? 3 Stocks You Should Know About

PennyStocks·5/2/2021·↓ negative

Outlook Therapeutics is bringing a treatment for retinal disease to the market at the right time

Proactive Investors·4/29/2021·↑ positive

Why Bausch Health, Oncolytics Biotech, And More Are Moving Today

Benzinga·2/17/2021·↓ negative

Outlook Therapeutics Reports Financial Results for Fiscal Year 2020 and Provides Corporate Update

GlobeNewsWire·12/23/2020·↑ positive

Outlook Therapeutics Announces Creation of Global Retina Advisory Council

GlobeNewsWire·11/19/2020·↑ positive

Virtual KOL Roundtable Recap: Outlook Therapeutics and Firas Rahhal, MD, Discussed wet AMD Treatment Landscape and ONS-5010/LYTENAVA™

GlobeNewsWire·11/11/2020·↑ positive

Outlook Therapeutics Secures $10 Million in Additional Working Capital

GlobeNewsWire·11/5/2020·↑ positive

Outlook Therapeutics Completes Patient Enrollment of Open-Label Safety Study for ONS-5010/LYTENAVA™ (bevacizumab-vikg)

GlobeNewsWire·11/3/2020·↑ positive

UK coronavirus live: Nicola Sturgeon sets out Scotland's new lockdown tiers; Warrington agrees to enter tier 3

theguardian·10/23/2020·↓ negative

Vaccines, vaping and the north-south divide: your Covid questions answered

theguardian·10/22/2020·↓ negative